Supplementary Table 1 List of 213 probes representing 87 MCB- over-expressed genes and 121DCB-over-expressed genes as determined by Statistical Analysis of Microarrays (SAM)  analysis with a false-discovery discovery rate up to 0.01.

Supplementary Table 3: Genes associated with Treatment-Free Survival

Table S3. Genes ranked by differential expression in 5q- CD34+CD38?Thy-1+ stem cells  compared to normal CD34+CD38?Thy-1+ stem cells

Table S1. Genes sorted as up-regulated and down-regulated in normal CD34+CD38?Thy-1+ stem cells  compared to normal CD34+CD38+Thy-1? progenitors

Table 3. Differentially expressed genes in 5q? versus normal CD34+CD38?Thy-1+ cells

Table III. Genes expressed in PP organizer cells >2-fold increase than in MLN organizer cells

Table II. Genes expressed in MLN organizer cells >2-fold increase than in PP organizer cells

Supplemental Table II. Expression profile of IGF-I -II and IGFBP-2 -3 in leukemic cells compared to healthy MNC.

Table 1 Genes differentially expressed in LNCaP treated with Dutasteride

Table 7 Genes up- and down-regulated in patients with poor response to treatment

Table 3 Cluster 2 selected up-regulated genes

Table 4 Cluster 3 selected up-regulated genes

Table 2 Cluster 1 selected up-regulated genes

Table 6. Genes differentiating clinical stage

Table 1a. Overexpressed genes in well-differentiated liposarcoma compared with normal fat

Supplementary table 4. Translationally regulated growth factors.

Supplementary table 1. Trascriptionally regulated genes.

Supplementary table 8. Translationally regulated translation related genes.

Supplementary table 2. Translationally regulated genes.

Table 1. Translationally regulated genes related to the cell cycle and apoptosis

Supplementary table 5.Translationally regulated cell cycle related genes

Supplementary table 7.Translationally regulated ribosomal genes.

Table 1. Gefitinib-induced changes in Bam1a gene expression

Table 2. Differential gene expression between gefitinib-sensitive (Bam1a) and gefitinib-resistant (IR-5) breast cancer cells